LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Internet Application Furthers Pediatric Cancer Research

By LabMedica International staff writers
Posted on 11 Jan 2016
Image: Researchers have developed a powerful interactive web application and data set tool to advance understanding of the mutations that lead to and fuel pediatric cancer (Photo courtesy of St. Jude Children\'s Research Hospital).
Image: Researchers have developed a powerful interactive web application and data set tool to advance understanding of the mutations that lead to and fuel pediatric cancer (Photo courtesy of St. Jude Children\'s Research Hospital).
An interactive web application and dataset that is a powerful tool to advance understanding of oncogenic mutations is available free of charge to pediatric cancer researchers.

The ProteinPaint web application was developed and is maintained by investigators at St. Jude Children's Research Hospital (Memphis, TN, USA). ProteinPaint integrates mutation information from multiple datasets obtained from the St. Jude Children's Research Hospital, the Washington University (St. Louis, MO, USA) Pediatric Cancer Genome Project, the [US] National Cancer Institute's (Bethesda, MD, USA) Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, and other published pediatric cancer studies.

Having access to this vast data base enables the program to identify mutations that are present only at diagnosis or at relapse, and to indicate whether the mutations occur in almost every cell (germline) or just cancer cells (somatic).

The ProteinPaint program, which was described in the December 29, 2015, online edition of the journal Nature Genetics, currently includes information on almost 27,500 mutations discovered in more than 1,000 pediatric patients with 21 cancer subtypes.

"Each day brings new information about mutations that drive human cancer. Novel tools are essential to help scientists use this wealth of genomic data to advance research and find new cures," said senior author Dr. Jinghui Zhang, professor of computational biology at St. Jude Children's Research Hospital. "We developed ProteinPaint as an intuitive tool any scientist can easily use to explore the vast amount of information now available on cancer genomics."

"ProteinPaint's focus on pediatric cancer and presentation of mutations at the gene level complements existing cancer genome data portals," said Dr. Zhang. "For St. Jude, the application is the foundation for developing a global reference database for information about pediatric cancer."

Related Links:

ProteinPaint - available to researchers free of charge
St. Jude Children's Research Hospital
Washington University

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more